共 50 条
- [31] Excess weight and anti-PD-1 immune checkpoint inhibitor’s outcomes in non-small cell lung cancerClinical and Translational Oncology, 2022, 24 : 2241 - 2249Jacobo RogadoFernando PozoKevin TrouléJosé Miguel Sánchez-TorresNuria Romero-LaordenRebeca MondejarOlga DonnayAnabel BallesterosVilma Pacheco-BarciaJavier AspaFátima Al-ShahrourArantzazu AlfrancaRamon Colomer
- [32] Profiling Immune-Related Adverse Events (irAEs) in Patients with Anti-PD-1 for Advanced Non-Small Cell Lung CancerJOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S598 - S599Toi, Y.Sugawara, S.Aso, M.Tsurumi, K.Ono, K.Sugisaka, J.Shimizu, H.Ono, H.Domeki, Y.Aiba, T.Kawana, S.Saito, R.Terayama, K.Kawashima, Y.Nakamura, A.Yamanda, S.Kimura, Y.Honda, Y.
- [33] Efficacy and Safety of Anti-PD-1 Inhibitors in Elderly Patients with Advanced Non-Small Cell Lung CancerJOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S979 - S980Tanaka, Y.Okano, T.Kudo, Y.Takeuchi, S.Makino, Y.Shimada, Y.Maehara, S.Hagiwara, M.Kakihana, M.Kajiwara, N.Ohira, T.Ikeda, N.
- [34] Predictive biomarker of response to anti-PD-1 treatment in non-small cell lung cancer patients.JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (05)Zheng, XuanHu, YiMa, JunxunZhang, FanSun, DanyangLi, Lingling
- [35] Anti-PD-1 Inhibitor-Related Pneumonitis in Non-Small Cell Lung CancerCANCER IMMUNOLOGY RESEARCH, 2016, 4 (04) : 289 - 293Nishino, MizukiChambers, Emily S.Chong, Curtis R.Ramaiya, Nikhil H.Gray, Stacy W.Marcoux, J. PaulHatabu, HirotoJanne, Pasi A.Hodi, F. StephenAwad, Mark M.
- [37] Prognostic Nomogram for Advanced Non-Small Cell Lung Cancer Patients Treated With Anti-PD-1 InhibitorsJOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S254 - S255Chai, R.Fan, Y.Zhao, J.He, F.Han, Y.
- [38] Serum immune modulators during the first cycle of anti-PD-1 antibody therapy in non-small cell lung cancer: Perforin as a biomarkerTHORACIC CANCER, 2020, 11 (11) : 3223 - 3233Ota, TakayoFukui, TomoyaNakahara, YoshiroTakeda, TakayukiUchino, JunjiMouri, TakakoKudo, KeitaNakajima, SakiSuzumura, TomohiroFukuoka, Masahiro
- [39] Peripheral natural killer cells and myeloid-derived suppressor cells correlate with anti-PD-1 responses in non-small cell lung cancerSCIENTIFIC REPORTS, 2020, 10 (01)Youn, Je-InPark, Su-MyeongPark, SeyeonKim, GaminLee, Hee-JaeSon, JiminHong, Min HeeGhaderpour, AzizBaik, BumseoIslam, JahirulChoi, Ji-WoongLee, Eun-YoungKim, Hang-RaeSeo, Sang-UkPaik, SoonmyungYoon, Hong InJung, InkyungXin, Chun-FengJin, Hyun-TakCho, Byoung ChulSeong, Seung-YongHa, Sang-JunKim, Hye Ryun
- [40] Peripheral natural killer cells and myeloid-derived suppressor cells correlate with anti-PD-1 responses in non-small cell lung cancerScientific Reports, 10Je-In YounSu-Myeong ParkSeyeon ParkGamin KimHee-Jae LeeJimin SonMin Hee HongAziz GhaderpourBumseo BaikJahirul IslamJi-Woong ChoiEun-Young LeeHang-Rae KimSang-Uk SeoSoonmyung PaikHong In YoonInkyung JungChun-Feng XinHyun-Tak JinByoung Chul ChoSeung-Yong SeongSang-Jun HaHye Ryun Kim